Explore 3 Stock Ideas & Industry Insights Download Free Report

ZEN Graphene Solutions Ltd

Company price
0.53 CAD 0.00(0%)
Last update at 2026-11-04T20:40:00Z
VOLUME
71643
Market Cap
75.28M

Momentum Score

…

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also developing aptamers and rapid detection; and graphene oxide synthesis and graphene synthesis products. In addition, the company owns a 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.52
Low
0.53
High
52 Week Price Range
0.63
Low
2.50
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

ZEN Graphene Solutions Ltd develops and seeks to commercialize graphene and related advanced materials for industrial uses like composites, coatings, filtration and energy storage. Long-term growth drivers include rising demand for specialty materials, successful manufacturing scale-up and technology licensing that could support recurring revenue. Investors may find exposure attractive if R&D and pilot work translate into scalable sales.

Key risk is execution: achieving consistent, high-quality production, securing commercial customers or partners and obtaining financing without excessive dilution.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.53
Dividend Yield
-
Revenue TTM
0.94M
Revenue Per Share
0.01
Gross Profit TTM
0.48M
Debt / Equity
0.06
ROE
-56.64%
Net Debt
0.23M
ROCE
-64.39%
Diluted EPS TTM
-0.08

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax -10.04M -11.80M -14.41M -12.02M -3.87M
Net income -10.04M -11.70M -14.41M -38.69M -3.87M
Selling general administrative 8.01M 8.57M 10.62M 10.25M 4.20M
Selling and marketing expenses - 0.38M 0.31M 0.28M 0.07M
Gross profit 0.19M -0.30M -0.78M -0.28M -0.12M
Reconciled depreciation 0.60M 0.61M 0.54M 0.61M 0.13M
Ebit - -11.54M -14.15M -11.96M -3.98M
Ebitda - -10.93M -13.61M -11.34M -3.86M
Depreciation and amortization - 0.61M 0.54M 0.61M 0.13M
Operating income -9.60M -11.54M -14.15M -12.56M -3.98M
Other operating expenses - 12.01M 14.73M 12.32M 3.98M
Interest expense 0.09M 0.11M 0.12M 0.06M 0.01M
Tax provision 0.00M -0.10M 0.00M - -
Interest income 0.10M 0.41M 0.51M 0.02M 0.01M
Net interest income 0.01M 0.29M 0.38M -0.04M 0.01M
Income tax expense - -0.10M 0.12M 26.74M -0.01M
Total revenue 0.87M 0.03M 0.07M 0.34M 0.00M
Total operating expenses 10.47M 11.68M 14.73M 12.32M 3.98M
Cost of revenue 0.68M 0.33M 0.85M 0.61M 0.13M
Total other income expense net -0.44M -0.12M -0.15M 0.00M 0.11M
Discontinued operations - - - -26.67M -26.67M
Net income from continuing ops -10.04M -11.70M -14.41M -12.02M -3.87M
Net income applicable to common shares - - - -31.69M -3.87M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 18.40M 22.59M 33.29M 37.98M 30.25M
Other current assets - 0.47M - - -
Total liab 3.65M 2.41M 2.90M 3.44M 2.79M
Total stockholder equity 14.75M 20.17M 30.38M 34.55M 27.46M
Other current liab - 0.63M - - 2.01M
Common stock - 86.11M - 85.49M 43.80M
Capital stock 89.48M 86.11M 85.75M 85.49M 43.80M
Retained earnings -83.85M -76.62M -66.20M -52.18M -20.49M
Cash 0.12M 3.52M 10.36M 26.68M 3.09M
Total current liabilities 3.49M 1.82M 2.42M 2.30M 2.51M
Net debt 0.23M -2.28M - - -
Short term debt - 0.65M - - -
Short long term debt 0.35M 0.50M 1.00M 0.95M -
Short long term debt total - 1.24M - - -
Other stockholder equity - - - 8.23M 4.15M
Property plant equipment - - - 13.03M 26.86M
Total current assets 4.37M 6.25M 17.95M 31.96M 3.39M
Net tangible assets - - - 41.55M 27.46M
Short term investments - 3.00M - - -
Net receivables 0.85M 0.84M 0.01M 3.61M 0.12M
Long term debt - 0.26M - 1.00M -
Inventory 0.89M 1.42M 2.96M 1.52M -
Accounts payable 2.01M 0.54M 0.91M 1.04M 0.35M
Accumulated other comprehensive income - 10.69M - - -
Non currrent assets other 1.29M 1.29M - - -
Non current assets total 14.03M 16.34M 15.34M 6.03M 26.86M
Capital lease obligations 0.33M 0.48M 0.61M 0.28M 0.40M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments 0.36M 1.88M -2.31M -7.25M -1.23M
Change to liabilities - - -0.02M 0.83M 0.06M
Total cashflows from investing activities - - - -7.25M -1.23M
Net borrowings -0.56M - - -0.12M -0.07M
Total cash from financing activities 2.52M -0.67M -1.05M 38.82M 5.31M
Change to operating activities - - -0.18M -0.99M 0.02M
Net income -10.04M -11.70M -14.41M -12.02M -3.87M
Change in cash -3.40M -6.84M -16.32M 23.58M 2.29M
Begin period cash flow 3.52M 10.36M 26.68M 3.09M 0.81M
End period cash flow 0.12M 3.52M 10.36M 26.68M 3.09M
Total cash from operating activities -6.28M -8.05M -12.96M -7.99M -1.79M
Issuance of capital stock 3.07M - 31.01M 35.34M 2.05M
Depreciation 0.60M 0.61M 0.54M 0.61M 0.13M
Other cashflows from investing activities - - - -0.32M -0.98M
Change to inventory 0.40M -0.07M -2.18M -0.67M -0.67M
Change to account receivables - 0.27M -0.01M -0.54M -0.04M
Sale purchase of stock - -0.41M - - -
Other cashflows from financing activities - -0.41M 0.05M 3.60M 3.34M
Change to netincome - - - 4.77M 1.91M
Capital expenditures 0.18M 0.32M 2.27M 3.99M 0.25M
Change in working capital 1.48M 0.91M -2.40M -1.36M 0.04M
Stock based compensation 1.53M 1.79M 3.20M 4.73M 2.02M
Other non cash items - -0.02M 0.11M 0.05M -0.11M
Free cash flow -6.47M -8.37M -15.23M -11.97M -2.05M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ZEN
ZEN Graphene Solutions Ltd
-
-%
0.53 - - 79.84 5.93 77.67 -14.24
OTC
Ocumetics Technology Corp
-
-%
0.40 - - - 41.07 - -79.74
COV
Covalon Technologies Ltd.
-0.11
2.52%
4.26 65.00 23.81 1.71 2.04 1.21 26.39

Profile*

ZEN Graphene Solutions Ltd

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also developing aptamers and rapid detection; and graphene oxide synthesis and graphene synthesis products. In addition, the company owns a 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

24 Corporate Court, Guelph, ON, Canada, N1G 5G5

844 730 9822

18

Name Title Year Born
Mr. Cassio Bobsin Machado Founder, CEO, Chairman & Interim Chief Sales Officer 1981
Mr. Shay Chor Chief Financial Officer 1977
Ms. Lilian Lima Chief Technology Officer 1968
Ms. Gabriela Ferreira Vargas Chief Marketing Officer 1987
Ms. Katiuscia Alice Teixeira Chief People Officer & Chief HR Officer 1991
Mr. Raphael Godoy Chief Revenue Officer of SaaS 1983
Luca Bazuro Chief Revenue Officer of Consulting NA
Cristiano Franco Chief Revenue Officer of CPaaS NA
Ms. Mariana Cambiaghi Chief Controller Officer & Fin. Exec. Director 1981
Mr. Gregory Fenton C.F.A. CEO & Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…